Literature DB >> 23749481

Effects of qigong exercise on upper limb lymphedema and blood flow in survivors of breast cancer: a pilot study.

Shirley S M Fong1, Shamay S M Ng, W S Luk, Joanne W Y Chung, Jacqueline S C Ho, Michael Ying, Ada W W Ma.   

Abstract

HYPOTHESIS: Qigong exercise is a popular method for relieving the side effects of conventional cancer treatments in survivors of breast cancer, yet its effects are not empirically assessed. This study aimed to investigate the effects of qigong exercise on upper limb lymphedema, arterial resistance, and blood flow velocity in survivors with breast cancer and mastectomy. STUDY
DESIGN: This study was conducted as a prospective clinical trial.
METHODS: Eleven survivors of breast cancer with qigong experience (mean age = 58.3 ± 10.1 years) were assigned to the experimental group and 12 survivors of breast cancer without qigong experience (mean age = 53.8 ± 4.2 years) were assigned to the control group. They all had breast cancer-related lymphedema. All procedures were completed within one session. After baseline measurements were taken, the experimental group performed 18 Forms Tai Chi Internal Qigong for approximately 6 minutes while the control group rested for similar duration in a sitting position. Both groups were then reassessed. All participants were measured on their affected upper limb circumference (by using tape measures), peripheral arterial resistance, and blood flow velocities (using a Doppler ultrasound machine).
RESULTS: The between-group differences were not significant for all outcome measures at baseline (P > .05). The circumferences of the affected upper arm, elbow, forearm and wrist decreased after qigong exercise (P < .05). However, no significant difference was found in the circumference measures between the 2 groups posttest (P > .0125). In terms of vascular outcomes, the resistance index decreased and the maximum systolic arterial blood flow velocity (SV) and minimum diastolic arterial blood flow velocity (DV) increased significantly after qigong exercise (P < .05). The between-group difference was close to significant for SV (P = .018) and was significant for DV (P < .001) posttest.
CONCLUSION: Qigong exercise could reduce conventional cancer therapy side effects such as upper limb lymphedema and poor circulatory status in survivors of breast cancer. However, such effects may be temporary, and further studies must be conducted to explore longer term effects.

Entities:  

Keywords:  arm swelling; breast carcinoma; complementary therapy; peripheral circulation; postmastectomy; side effects; tai chi qigong

Mesh:

Year:  2013        PMID: 23749481     DOI: 10.1177/1534735413490797

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  12 in total

1.  Effects of a 6-month Tai Chi Qigong program on arterial hemodynamics and functional aerobic capacity in survivors of nasopharyngeal cancer.

Authors:  Shirley S M Fong; Shamay S M Ng; W S Luk; Joanne W Y Chung; Joyce C Y Leung; Rich S W Masters
Journal:  J Cancer Surviv       Date:  2014-06-08       Impact factor: 4.442

Review 2.  Mind-body practices in cancer care.

Authors:  Alejandro Chaoul; Kathrin Milbury; Anil K Sood; Sarah Prinsloo; Lorenzo Cohen
Journal:  Curr Oncol Rep       Date:  2014-12       Impact factor: 5.075

3.  Sustainable impact of an individualized exercise program on physical activity level and fatigue syndrome on breast cancer patients in two German rehabilitation centers.

Authors:  Freerk T Baumann; Oliver Bieck; Max Oberste; Rafaela Kuhn; Joachim Schmitt; Steffen Wentrock; Eva Zopf; Wilhelm Bloch; Klaus Schüle; Monika Reuss-Borst
Journal:  Support Care Cancer       Date:  2016-12-09       Impact factor: 3.603

4.  Qigong program on insomnia and stress in cancer patients: A case series report.

Authors:  Seungmo Kim; Sangnam Lee; Osung Kwon; Seonghoon Park; Jungchul Seo; Kyungsoon Kim
Journal:  SAGE Open Med Case Rep       Date:  2015-01-14

5.  Complementary Therapies for Symptom Management in Cancer Patients.

Authors:  Aanchal Satija; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

6.  Bone Mineral Density, Balance Performance, Balance Self-Efficacy, and Falls in Breast Cancer Survivors With and Without Qigong Training: An Observational Study.

Authors:  Shirley S M Fong; Anna W M Choi; W S Luk; Timothy T T Yam; Joyce C Y Leung; Joanne W Y Chung
Journal:  Integr Cancer Ther       Date:  2017-01-04       Impact factor: 3.279

7.  The effect of Three-Circle Post Standing (Zhanzhuang) Qigong on the physical and psychological well-being of college students: Study protocol for a randomized controlled trial.

Authors:  Yu Guo; Mingmin Xu; Jialei Zhang; Qingchuan Hu; Zhengkun Zhou; Zeren Wei; Jian Yan; Yue Chen; Jianxuan Lyu; Xiaoqian Shao; Ying Wang; Jiamei Guo; Yulong Wei
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

8.  Effects of a 12-week resistance and aerobic exercise program on muscular strength and quality of life in breast cancer survivors: Study protocol for the EFICAN randomized controlled trial.

Authors:  Alberto Soriano-Maldonado; Álvaro Carrera-Ruiz; David M Díez-Fernández; Alba Esteban-Simón; Mercedes Maldonado-Quesada; Nuria Moreno-Poza; María Del Mar García-Martínez; Celia Alcaraz-García; Rosa Vázquez-Sousa; Herminia Moreno-Martos; Antonio Toro-de-Federico; Nur Hachem-Salas; Eva Artés-Rodríguez; Manuel A Rodríguez-Pérez; Antonio J Casimiro-Andújar
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 9.  Physical activity for women with breast cancer after adjuvant therapy.

Authors:  Ian M Lahart; George S Metsios; Alan M Nevill; Amtul R Carmichael
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29

10.  Safety of Qigong: Protocol for an overview of systematic reviews.

Authors:  Yu Guo; Mingmin M Xu; Yuchang Huang; Meiqi Ji; Zeren Wei; Jialei Zhang; Qingchuan Hu; Jian Yan; Yue Chen; Jiaxuan Lyu; Xiaoqian Shao; Ying Wang; Jiamei Guo; Yulong Wei
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.